INSM logo

Insmed Incorporated (INSM) EBITDA

Annual EBITDA:

-$818.79M-$158.62M(-24.03%)
December 31, 2024

Summary

  • As of today, INSM annual EBITDA is -$818.79 million, with the most recent change of -$158.62 million (-24.03%) on December 31, 2024.
  • During the last 3 years, INSM annual EBITDA has fallen by -$435.15 million (-113.42%).
  • INSM annual EBITDA is now -780.54% below its all-time high of $120.31 million, reached on December 31, 2009.

Performance

INSM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINSMincome statement metrics

Quarterly EBITDA:

-$297.13M-$64.35M(-27.64%)
June 30, 2025

Summary

  • As of today, INSM quarterly EBITDA is -$297.13 million, with the most recent change of -$64.35 million (-27.64%) on June 30, 2025.
  • Over the past year, INSM quarterly EBITDA has dropped by -$20.23 million (-7.31%).
  • INSM quarterly EBITDA is now -345.49% below its all-time high of $121.04 million, reached on March 31, 2009.

Performance

INSM Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINSMincome statement metrics

TTM EBITDA:

-$938.10M-$20.23M(-2.20%)
June 30, 2025

Summary

  • As of today, INSM TTM EBITDA is -$938.10 million, with the most recent change of -$20.23 million (-2.20%) on June 30, 2025.
  • Over the past year, INSM TTM EBITDA has dropped by -$228.47 million (-32.20%).
  • INSM TTM EBITDA is now -879.70% below its all-time high of $120.31 million, reached on December 31, 2009.

Performance

INSM TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINSMincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

INSM EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-24.0%-7.3%-32.2%
3Y3 Years-113.4%-228.7%-146.7%
5Y5 Years-277.2%-485.0%-364.4%

INSM EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-113.4%at low-135.6%at low-131.1%at low
5Y5-Year-277.2%at low-461.0%at low-364.4%at low
All-TimeAll-Time-780.5%at low-345.5%at low-879.7%at low

INSM EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
-$297.13M(-27.6%)
-$938.10M(-2.2%)
Mar 2025
-
-$232.78M(-9.9%)
-$917.87M(-12.1%)
Dec 2024
-$818.79M(-24.0%)
-$211.74M(-7.8%)
-$818.79M(-6.4%)
Sep 2024
-
-$196.45M(+29.1%)
-$769.56M(-8.4%)
Jun 2024
-
-$276.89M(-107.1%)
-$709.62M(-8.3%)
Mar 2024
-
-$133.71M(+17.7%)
-$655.47M(+0.7%)
Dec 2023
-$660.18M(-47.6%)
-$162.50M(-19.0%)
-$660.18M(-3.3%)
Sep 2023
-
-$136.52M(+38.7%)
-$639.30M(-1.7%)
Jun 2023
-
-$222.74M(-60.9%)
-$628.91M(-26.7%)
Mar 2023
-
-$138.42M(+2.3%)
-$496.56M(-11.0%)
Dec 2022
-$447.37M(-16.6%)
-$141.63M(-12.3%)
-$447.37M(-10.2%)
Sep 2022
-
-$126.13M(-39.5%)
-$405.91M(-6.7%)
Jun 2022
-
-$90.39M(-1.3%)
-$380.33M(+3.3%)
Mar 2022
-
-$89.22M(+10.9%)
-$393.13M(-2.3%)
Dec 2021
-$383.65M(-53.2%)
-$100.18M(+0.4%)
-$384.45M(-2.5%)
Sep 2021
-
-$100.55M(+2.6%)
-$375.14M(-14.5%)
Jun 2021
-
-$103.19M(-28.1%)
-$327.56M(-19.0%)
Mar 2021
-
-$80.54M(+11.4%)
-$275.16M(-9.9%)
Dec 2020
-$250.37M(-15.3%)
-$90.87M(-71.6%)
-$250.37M(-24.0%)
Sep 2020
-
-$52.96M(-4.3%)
-$201.98M(-0.6%)
Jun 2020
-
-$50.79M(+8.9%)
-$200.80M(+3.3%)
Mar 2020
-
-$55.75M(-31.2%)
-$207.58M(+4.4%)
Dec 2019
-$217.07M(+26.5%)
-$42.48M(+18.0%)
-$217.07M(+15.7%)
Sep 2019
-
-$51.78M(+10.0%)
-$257.61M(+10.0%)
Jun 2019
-
-$57.56M(+11.8%)
-$286.31M(+3.9%)
Mar 2019
-
-$65.24M(+21.4%)
-$298.01M(-1.0%)
Dec 2018
-$295.18M(-59.7%)
-$83.02M(-3.1%)
-$295.18M(-7.0%)
Sep 2018
-
-$80.48M(-16.2%)
-$275.89M(-15.7%)
Jun 2018
-
-$69.27M(-11.0%)
-$238.55M(-12.7%)
Mar 2018
-
-$62.41M(+2.1%)
-$211.69M(-14.6%)
Dec 2017
-$184.87M(-8.6%)
-$63.73M(-47.7%)
-$184.67M(+1.3%)
Sep 2017
-
-$43.14M(-1.7%)
-$187.15M(-3.8%)
Jun 2017
-
-$42.41M(-19.8%)
-$180.31M(-4.1%)
Mar 2017
-
-$35.40M(+46.5%)
-$173.27M(-1.8%)
Dec 2016
-$170.24M(-47.7%)
-$66.21M(-82.4%)
-$170.24M(-25.3%)
Sep 2016
-
-$36.29M(-2.6%)
-$135.88M(-5.0%)
Jun 2016
-
-$35.37M(-9.3%)
-$129.36M(-6.5%)
Mar 2016
-
-$32.37M(-1.6%)
-$121.44M(-5.3%)
Dec 2015
-$115.28M(-33.9%)
-$31.85M(-7.0%)
-$115.28M(-8.6%)
Sep 2015
-
-$29.77M(-8.5%)
-$106.11M(-6.8%)
Jun 2015
-
-$27.44M(-4.7%)
-$99.38M(-5.3%)
Mar 2015
-
-$26.21M(-15.6%)
-$94.39M(-9.6%)
Dec 2014
-$86.09M(-58.8%)
-$22.68M(+1.5%)
-$86.09M(-9.2%)
Sep 2014
-
-$23.04M(-2.6%)
-$78.81M(-8.9%)
Jun 2014
-
-$22.45M(-25.3%)
-$72.40M(-24.8%)
Mar 2014
-
-$17.91M(-16.3%)
-$58.01M(-7.0%)
Dec 2013
-$54.20M(-35.3%)
-$15.40M(+7.4%)
-$54.20M(-1.2%)
Sep 2013
-
-$16.63M(-106.3%)
-$53.57M(-16.6%)
Jun 2013
-
-$8.06M(+42.8%)
-$45.96M(+3.1%)
Mar 2013
-
-$14.11M(+4.5%)
-$47.45M(-18.5%)
Dec 2012
-$40.05M
-$14.77M(-63.7%)
-$40.05M(-20.1%)
Sep 2012
-
-$9.02M(+5.6%)
-$33.34M(+43.3%)
DateAnnualQuarterlyTTM
Jun 2012
-
-$9.55M(-42.5%)
-$58.82M(+0.6%)
Mar 2012
-
-$6.71M(+16.7%)
-$59.20M(+0.2%)
Dec 2011
-$59.31M(-857.7%)
-$8.05M(+76.7%)
-$59.31M(-4.1%)
Sep 2011
-
-$34.51M(-247.4%)
-$56.99M(-150.7%)
Jun 2011
-
-$9.94M(-45.8%)
-$22.74M(-72.6%)
Mar 2011
-
-$6.81M(-18.8%)
-$13.18M(-112.8%)
Dec 2010
-$6.19M(-105.1%)
-$5.74M(-2167.2%)
-$6.19M(-1569.3%)
Sep 2010
-
-$253.00K(+32.5%)
-$371.00K(-165.0%)
Jun 2010
-
-$375.00K(-319.3%)
-$140.00K(+74.5%)
Mar 2010
-
$171.00K(+98.8%)
-$550.00K(-100.5%)
Dec 2009
$120.31M(+1000.0%)
$86.00K(+490.9%)
$120.31M(+3.1%)
Sep 2009
-
-$22.00K(+97.2%)
$116.72M(+1.4%)
Jun 2009
-
-$785.00K(-100.6%)
$115.11M(+3.0%)
Mar 2009
-
$121.04M(+3550.3%)
$111.73M(+908.8%)
Dec 2008
-$13.37M(+33.3%)
-$3.51M(-114.6%)
-$13.81M(-2.3%)
Sep 2008
-
-$1.64M(+60.7%)
-$13.50M(+15.1%)
Jun 2008
-
-$4.17M(+7.6%)
-$15.90M(-11.8%)
Mar 2008
-
-$4.51M(-40.9%)
-$14.22M(+29.0%)
Dec 2007
-$20.03M(+60.7%)
-$3.20M(+20.7%)
-$20.03M(+47.0%)
Sep 2007
-
-$4.03M(-62.4%)
-$37.77M(+18.6%)
Jun 2007
-
-$2.48M(+75.9%)
-$46.37M(+12.7%)
Mar 2007
-
-$10.32M(+50.7%)
-$53.13M(-4.2%)
Dec 2006
-$51.00M(-250.9%)
-$20.93M(-65.7%)
-$51.00M(-62.0%)
Sep 2006
-
-$12.64M(-36.7%)
-$31.48M(-49.4%)
Jun 2006
-
-$9.24M(-12.8%)
-$21.07M(-20.9%)
Mar 2006
-
-$8.19M(-482.0%)
-$17.43M(-19.9%)
Dec 2005
-$14.54M(+46.9%)
-$1.41M(+36.8%)
-$14.54M(+23.5%)
Sep 2005
-
-$2.23M(+60.2%)
-$19.01M(+22.2%)
Jun 2005
-
-$5.60M(-5.8%)
-$24.42M(+12.4%)
Mar 2005
-
-$5.30M(+9.9%)
-$27.87M(-1.7%)
Dec 2004
-$27.39M(-161.1%)
-$5.88M(+23.0%)
-$27.39M(-14.1%)
Sep 2004
-
-$7.64M(+15.6%)
-$24.00M(-27.6%)
Jun 2004
-
-$9.05M(-87.7%)
-$18.80M(-44.2%)
Mar 2004
-
-$4.82M(-93.7%)
-$13.04M(-24.3%)
Dec 2003
-$10.49M(+69.3%)
-$2.49M(-1.8%)
-$10.49M(+60.6%)
Sep 2003
-
-$2.44M(+25.6%)
-$26.60M(-1.0%)
Jun 2003
-
-$3.29M(-44.6%)
-$26.34M(+12.8%)
Mar 2003
-
-$2.27M(+87.8%)
-$30.23M(+11.5%)
Dec 2002
-$34.15M(+11.6%)
-$18.60M(-750.6%)
-$34.15M(-34.9%)
Sep 2002
-
-$2.19M(+69.5%)
-$25.32M(+20.2%)
Jun 2002
-
-$7.17M(-15.7%)
-$31.74M(+6.2%)
Mar 2002
-
-$6.19M(+36.7%)
-$33.85M(+12.4%)
Dec 2001
-$38.64M(-27.5%)
-$9.78M(-13.5%)
-$38.64M(-398.4%)
Sep 2001
-
-$8.61M(+7.1%)
$12.95M(-20.7%)
Jun 2001
-
-$9.27M(+15.7%)
$16.34M(+154.6%)
Mar 2001
-
-$10.99M(-126.3%)
-$29.90M(+1.3%)
Dec 2000
-$30.31M(-276.9%)
$41.82M(+900.2%)
-$30.31M(+58.0%)
Sep 2000
-
-$5.23M(+90.6%)
-$72.13M(-7.8%)
Jun 2000
-
-$55.51M(-387.0%)
-$66.90M(-412.5%)
Mar 2000
-
-$11.40M(-587.8%)
-$13.05M(-305.7%)
Dec 1999
-$8.04M
-
-
Jun 1999
-
-$1.66M(-6.1%)
-$3.22M(-106.1%)
Mar 1999
-
-$1.56M
-$1.56M

FAQ

  • What is Insmed Incorporated annual EBITDA?
  • What is the all-time high annual EBITDA for Insmed Incorporated?
  • What is Insmed Incorporated annual EBITDA year-on-year change?
  • What is Insmed Incorporated quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Insmed Incorporated?
  • What is Insmed Incorporated quarterly EBITDA year-on-year change?
  • What is Insmed Incorporated TTM EBITDA?
  • What is the all-time high TTM EBITDA for Insmed Incorporated?
  • What is Insmed Incorporated TTM EBITDA year-on-year change?

What is Insmed Incorporated annual EBITDA?

The current annual EBITDA of INSM is -$818.79M

What is the all-time high annual EBITDA for Insmed Incorporated?

Insmed Incorporated all-time high annual EBITDA is $120.31M

What is Insmed Incorporated annual EBITDA year-on-year change?

Over the past year, INSM annual EBITDA has changed by -$158.62M (-24.03%)

What is Insmed Incorporated quarterly EBITDA?

The current quarterly EBITDA of INSM is -$297.13M

What is the all-time high quarterly EBITDA for Insmed Incorporated?

Insmed Incorporated all-time high quarterly EBITDA is $121.04M

What is Insmed Incorporated quarterly EBITDA year-on-year change?

Over the past year, INSM quarterly EBITDA has changed by -$20.23M (-7.31%)

What is Insmed Incorporated TTM EBITDA?

The current TTM EBITDA of INSM is -$938.10M

What is the all-time high TTM EBITDA for Insmed Incorporated?

Insmed Incorporated all-time high TTM EBITDA is $120.31M

What is Insmed Incorporated TTM EBITDA year-on-year change?

Over the past year, INSM TTM EBITDA has changed by -$228.47M (-32.20%)
On this page